Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Invasive mucinous adenocarcinoma carries elevated NRG1 fusion burden that standard DNA-based sequencing reliably misses, while an FDA-approved targeted therapy now exists for confirmed cases.
Hematology/Oncology May 12th 2026
Hematology Advisor
A SARS-CoV-2 variant designated BA.3.2, or “Cicada,” has been added to the WHO variants under monitoring list, with wastewater detection across at least 25 US states and 132 locations.
Emergency Medicine May 8th 2026
Pulmonology Advisor
A DNA methylation–based IgE score measured in infancy was associated with recurrent wheezing by age 3 across three pediatric cohorts.
Allergy & Immunology May 7th 2026
Conexiant
The American Academy of Sleep Medicine just clarified where combination therapy fits for chronic insomnia. Spoiler: CBT-I still wins, but pharmacotherapy alone has a narrower role.
Neurology April 30th 2026
Annals of Internal Medicine
The OSPREY trial puts proximal hypoglossal nerve stimulation on the map for moderate-to-severe OSA, with strong short-term numbers and the limitations a small unblinded RCT carries.
Oncology Learning Network
Osimertinib plus datopotamab deruxtecan produced 20.5-month median duration of response at the 6 mg/kg dose in EGFR-mutated NSCLC after first-line osimertinib progression in the ORCHARD platform substudy.
Hematology/Oncology April 28th 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS